Guide · 3 min read

QOF 2026/27: what's changed and what it means for GP practices

Six new indicators, reweighted statin points and new blood pressure targets. Here's what changed in QOF this year and where the points now are.

Checked against the sources listed at the end on .

The short answer

The Quality and Outcomes Framework (QOF) is the annual reward and incentive programme for GP practices in England. Practices earn points for the care they record against each indicator, and each point is paid at a set value. For 2026/27 that value is £227.95, up from £225.49 in 2025/26.

NHS England imposed the 2026/27 changes after GPC England rejected the contract offer. The changes are meant to bring QOF closer to current NICE guidance. They add 18 points, worth around £25 million nationally, and move points from retired indicators to new ones. The QOF year runs from 1 April 2026 to 31 March 2027.

Most of the new and reweighted points are for medicines: heart failure therapy, statins in diabetes, obesity treatment and blood pressure control. That makes this year's QOF a medicines optimisation job as much as a coding one.

The new indicators

IndicatorWhat it measuresThresholdsPoints
CD001Blood pressure 140/90 mmHg or less in patients with coronary heart disease, stroke or TIA, aged 79 or under, without moderate or severe frailty40 to 90%41
CD002Blood pressure control in the same patients aged 80 or over, without moderate or severe frailty46 to 90%20
DM037People with diabetes who received all 8 NICE-recommended care processes in the year35 to 75%10
HF009People with heart failure with reduced ejection fraction on "4-pillar" therapy20 to 50%12
OB004Adults with obesity referred to a weight management programme10 to 30%5
OB005Shared decision-making and medicines for obesity in eligible patients50 to 80%13

CD001 and CD002 replace the separate coronary heart disease and stroke blood pressure indicators. DM037 asks for all eight care processes together, so one missed test means the patient doesn't count.

What changed in existing indicators

  • Hypertension: HYP010 and HYP011 replace HYP008 and HYP009, with the frailty cohort removed. HYP010 is worth 38 points and HYP011 14, both at 40 to 85%.
  • Statins in diabetes: DM034 (primary prevention) goes from 4 to 8 points and DM035 (secondary prevention) from 2 to 8. Thresholds stay at 50 to 90%.
  • Cholesterol: CHOL003 keeps its 70 to 95% thresholds but drops from 38 to 20 points.
  • Atrial fibrillation: AF006's upper threshold rises from 90% to 95%. Points stay at 12.
  • Non-diabetic hyperglycaemia: NDH003 replaces NDH002, adds people with a history of gestational diabetes and goes from 18 to 20 points.
  • Stroke and TIA: ticagrelor now counts as an antiplatelet for STIA007.
  • Registers: the asthma register now starts at age 5, and the COPD register rules were changed after an audit found both under- and over-recording.
  • Childhood vaccinations: VI002 and VI003 now include MMRV. Thresholds are unchanged, but practices can also earn points for improving on their own two-year average and are paid whichever is higher.

The retired indicator IDs are CHD015, CHD016, DM012, HF003, HF006, HYP008, HYP009, NDH002, STIA014 and STIA015. The Weight Management Enhanced Service has also been retired.

Where the medicines work is

Heart failure (HF009). NICE recommends four classes of medicine for heart failure with reduced ejection fraction. Getting patients onto all four usually means several reviews, titration and monitoring of kidney function and potassium, which is structured medication review work.

Statins in diabetes (DM034 and DM035). These now carry 16 points between them. The patients are already on the diabetes register; the work is finding those without a statin, reviewing them and offering or restarting one.

Blood pressure (CD001, CD002, HYP010, HYP011). The targets depend on age and frailty, so coding frailty correctly matters as much as titrating treatment. Patients coded as frail in a way QOF doesn't recognise may count against you.

Obesity (OB004 and OB005). OB005 rewards shared decision-making and prescribing for eligible patients. Eligibility for obesity medicines in primary care is being phased in by NHS England, so check the current criteria before you search.

Diabetes care processes (DM037). The eight checks are BMI, blood pressure, HbA1c, cholesterol, smoking status, foot check, urine albumin to creatinine ratio and eGFR. Because the indicator needs all eight, a search for patients with just one process outstanding finds the quickest wins.

Where your pharmacy team fits

A clinical pharmacist can run the searches, review the patients and make or recommend the medicine changes. They record each one so it counts. A pharmacy technician can work through recalls and outstanding care processes. Both free GPs to see the patients who need them.

If your practice or PCN doesn't have that capacity, our remote pharmacists and technicians can do this work inside your clinical system. Every piece of work appears in a monthly report. Talk to us about your practice.

Sources

  1. Changes to the GP Contract in 2026/27 (NHS England)
  2. Quality and Outcomes Framework guidance for 2026/27 (NHS England)
  3. Quality and outcomes framework (QOF) (BMA)
  4. Global sum increases by 5.4% for GP practices in 2026/27 (Pulse)
  5. QOF 2026/27: key changes your practice must act on (Primary Care IT)

More guides

All guides